Brokerage firm Morgan Stanley expects a more constructive, volume-led agchem cycle in 2026, which could support stronger asset utilisation and operating leverage-driven margin tailwinds, contrasting with the twin challenges of shaky demand and weak pricing that have defined FY25.
